Bioinformatics service

The Core Facility provides free experimental design consultation. Based on the user’s needs, we provide different levels of bioinformatics analysis, i.e. preprocessing of data, normalization, statistical analysis, annotation, gene ontology, and pathway analysis, in collaboration with the Bioinformatics Core Facility.
 
Primary and secondary analysis is performed using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT Platform at the Genomics Core Facility. This platform provides accurate, ultra-rapid primary and secondary genomic analysis of sequencing data. Multiple workflows are available.
 
Illumina DRAGEN Bio-IT Platform v3.9
 
DNA Pipeline (SNV/Indel, Copy Number Variants, Structural Variants, Repeat expansion, Ploidy, and more)
 
 
RNA Pipeline (Gene expression, Gene fusions, Variant calling, Single Cell)
 
 
Methylation Pipeline
 
 
Amplicon Pipeline
 
 
 
 
Pricing will include a license fee per Gb of data processed and personnel costs per hour. Contact us for more information.
 
The Genomics Core Facility has a close collaboration with the University of Oslo/Oslo University Hospital Bioinformatics core facility, which can assist in higher-level analysis.

 
 
 
 


News

Apr 21, 2023

The new ICR annual report is now available. Read about our science. Featuring a Spatial Transcriptomics picture on the cover.

Apr 16, 2023

Spike-in the TCR Profiling Add-On to GeoMx panel to spatially profile the expression of different T Cell Receptor (TCR).


Contact Information:

Genomics@rr-research.no

Daily Leader Core Facility
Susanne Lorenz, PhD

Susanne.Lorenz@rr-research.no

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

L.A.Meza-Zepeda@ous-research.no

Follow us via Twitter

@OSLOmicsCore

Visiting address:

Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

................................................................